ANGO

AngioDynamics, Inc. designs, manufactures, and sells medical devices for vascular access, peripheral vascular disease, and oncology applications. Headquartered in Latham, New York, the company operates with approximately 1,400 employees and maintains manufacturing facilities in the United States and Europe. AngioDynamics organizes its business around two primary segments: Med Tech, which includes vascular access products like PICCs, ports, and dialysis catheters, along with angiographic products and accessories; and Med Device, featuring thrombectomy systems, atherectomy devices, and its proprietary NanoKnife System for tumor ablation. The company distributes its products to interventional radiologists, vascular surgeons, and other physicians in hospitals and healthcare facilities globally. AngioDynamics generated approximately $300 million in annual revenue as of recent fiscal periods. The company focuses its strategic efforts on expanding its peripheral intervention franchise, particularly through its Auryon atherectomy laser platform and AlphaVac mechanical thrombectomy system. Recent developments include restructuring initiatives aimed at improving operational efficiency and concentrating resources on higher-growth product lines. AngioDynamics competes in specialized medical device markets against both large diversified healthcare companies and focused competitors, positioning itself through clinical differentiation and technological innovation in minimally invasive treatment solutions.